There is new, compelling evidence to suggest that all men who use testosterone therapy products have an increased risk of life-threatening blood clots. This remains true regardless of whether the patients have been diagnosed with hypogonadism or not. Testosterone therapy products, which include Axiron, Androgel, and Testim, have been under... Read more »

A motion was recently filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) that seeks to consolidate federal complaints filed with regard to valsartan, a generic hypertension drug. The motion was filed late in October 2018 by Robert Kruk on behalf of himself and other plaintiffs with pending valsartan lawsuits. Kruk... Read more »

The U.S. Food and Drug Administration (FDA) recently issued a new safety alert regarding the increased risk of Fournier’s gangrene among diabetes patients using Invokana and other drugs in the same class. Fournier’s gangrene is considered to be a rare, but very serious complication of SGLT2 inhibitors. This condition is... Read more »

Actavis, the makers of Androderm, has announced that there is a tentative settlement agreement in place that would resolve roughly 500 lawsuits. The plaintiffs involved with the litigation allege that they suffered serious complications as a result of their use of the defendants’ medicated testosterone patch. Actavis, which was acquired... Read more »

Plaintiffs who have filed product liability lawsuits against the manufacturers of popular proton pump inhibitors have requested that the judge schedule trial dates. The lawsuits were filed after plaintiffs claimed they sustained complications, including kidney injuries, after taking PPIs like Nexium, Prilosec, Prevacid, and Protonix. About 4,200 lawsuits have been... Read more »

A Mississippi man has filed a federal lawsuit against Janssen Pharmaceuticals that alleges that the defendant’s negligence caused him to suffer from severe, permanent medical complications. Jim Dedeaux was prescribed Invokana by his physician, a diabetes medication manufactured by the defendant. He took it as prescribed, assuming from the information... Read more »

Testosterone supplementation for older men has become big business for companies like Abbott Laboratories and AbbVie as they have marketed their testosterone products to the general population. Unfortunately, the benefits touted by these manufacturers may be overstated, new studies are finding. In fact, the risks associated with testosterone therapy might... Read more »

The U.S. Food and Drug Administration has issued a new safety alert regarding the type 2 diabetes drug canagliflozin — Invokana and Invokamet. The Agency issued a safety announcement on May 18, notifying patients and the medical community that results of an ongoing clinical trial revealed a higher number of... Read more »

Xarelto, a highly touted alternative to the blood-thinning medication Warfarin, has come under fire with questions about the clinical trial that led to its approval. Faulty equipment used to monitor some of the patients in the trial may have contributed to results that made Xarelto look superior to warfarin, leading... Read more »

The federal Food and Drug Administration (FDA) is tasked with the tremendous responsibility of keeping American consumers safe from dangerous drugs and medical devices. Accordingly, the agency has not only implemented strict pre-market testing and screening measures for new products, but it is required to monitor the products after their... Read more »